Retina Today
Share
Bringing you the latest research, clinical developments, and industry insights in surgical and medic A BMC Vision publication.
Retina Today is a publication that delivers the latest research and clinical developments from areas such as medical retina, retinal surgery, vitreous, diabetes, retinal imaging, pediatric retina, posterior segment oncology, and ocular trauma. Each issue provides insight from well-respected specialists on cutting-edge therapies and surgical techniques that are currently in use and on the horizon.
TKIs are moving through phase 3 for DME! Catch up on phase 2 VERONA clinical trial data of vorolanib (EYP-1901, Eyepoint), presented by Katherine E. Talcott, MD, at ARVO 2026.
Learn more here: https://ow.ly/inQp50Z2r3C
MacTel type 2 is a progressive neurodegenerative disease with ellipsoid zone loss on OCT. ENCELTO is the first FDA-approved therapy for adults with idiopathic MacTel type 2. Learn more: https://ow.ly/WMPR50ZeJ2E
See PI: https://ow.ly/xi2g50ZeJ2H.
06/20/2026
Registration is OPEN!
Don't miss the 27th Annual Advanced Vitreoretinal Techniques & Technology & Fellows’ Course, August 28–29, in Chicago!
Register NOW: https://ow.ly/oMGB50ZeqPV
06/19/2026
Can TKIs maintain vision for 6+ months in wet AMD? Akshay Thomas, MD, breaks down DAVIO-2 data on EYP-1901. Plus, Aaron Lee, MD, and Cecilia Lee, MD, on the future of AI in retina research. New Retina Radio is live. 👁️ https://ow.ly/AgmX50Zesh0
⭐️Fares Antaki, MDCM, FRCSC, is a Rising Star in Retina! He as always known he wanted to pursue retina, after watching his father’s practice. Learn about his path to retina, mentors, and favorite experience as a fellow: https://ow.ly/LgEM50ZcSeg
06/17/2026
A choroidal nevus in a 28-year-old patient raises an uncommon but important clinical question: when does observation become concern?
This case underscores why age alone should not drive surveillance decisions, particularly when multimodal imaging begins to show objective risk signals. Using TFSOM-DIM criteria, the authors walk through the clinical findings that shaped the evaluation without losing sight of measured, risk-based follow-up.
The result is a timely reminder that rare transformation can occur, and that documentation of growth remains central to early detection.
Read the case to see how the team approached a young patient with evolving features and why vigilance still matters across age groups here: https://ow.ly/mXBO50Zcmjt
MacTel Type 2 is increasingly understood as a neurodegenerative retinal disease. Ongoing clinical research is evaluating sustained intraocular delivery approaches designed to help address retinal cell loss and inform long-term disease management strategies.
Read more here: https://ow.ly/eNAo50ZbZ21
06/15/2026
🚩🦈 New on Retinaws: Explore expert perspectives on challenging retinal cases, from cloudy corneas and subretinal hemorrhages to pathologic myopia, trauma, retinoschisis RD, dislocated lenses, and more.
Catch up here: https://ow.ly/nctc50ZbWBh
06/13/2026
When GA and wet AMD overlap, treatment decisions become less straightforward.
Concurrent therapy may offer a path to longer-term vision preservation, but it also introduces new questions around scheduling, injection burden, monitoring, and prioritization. In this Retina Today article, Sean D. Adrean, MD, FAAO, and Wesley Han, BS, share clinical pearls for navigating this increasingly common scenario.
Their approach highlights the importance of proactive workflows, clear communication, and careful follow-up when two disease processes require ongoing attention. For clinicians managing patients with both GA and CNV, the details may make all the difference.
Read more here: https://ow.ly/rs1s50Zbixq
IL-6 inhibition for DME is showing promise, and Drs. Khanani and Goldberg shared phase 2 data at ARVO 2026. Catch the discussion with our video meeting coverage on Eyetube!
Watch the discussion here: https://ow.ly/Gwis50Z2r0T
Click here to claim your Sponsored Listing.
Category
Telephone
Website
Address
1008 Upper Gulph Road
Wayne, PA
19087